A tale of two balloons: technical and procedural difference between cryoballoon systems

The cryoballoon catheter has been an option for the treatment of atrial fibrillation for over a decade. The most widely used device is the Medtronic Arctic Advance cryoballoon catheter. Recently, Boston Scientific has released the POLARx cryoballoon catheter. Here we review the major changes in the...

Full description

Bibliographic Details
Published in:Current Opinion in Cardiology
Main Authors: Tomaiko-Clark, Emrie, Bai, Rong, Khokhar, Mateen, Su, Wilber W.
Format: Text
Language:English
Published: Lippincott Williams & Wilkins 2022
Subjects:
ARRHYTHMIAS: Edited by Wilber W. Su
Arctic
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711604/
http://www.ncbi.nlm.nih.gov/pubmed/34783712
https://doi.org/10.1097/HCO.0000000000000942
Description
Summary:The cryoballoon catheter has been an option for the treatment of atrial fibrillation for over a decade. The most widely used device is the Medtronic Arctic Advance cryoballoon catheter. Recently, Boston Scientific has released the POLARx cryoballoon catheter. Here we review the major changes in the catheter system's design and its implications for procedural practice. RECENT FINDINGS: The POLARx cryoballoon catheter has been approved for use in Europe. Some studies have been published detailing the first clinical experiences in vivo with this newest technology. SUMMARY: The changes to the POLARx cryoballoon catheter, particularly its ability to maintain balloon size and pressure, will improve occlusion and theoretically improve procedural outcomes.

Similar Items